BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33723144)

  • 1. Herbal supplement usage among cancer patients: A questionnaire-based survey.
    Kanimozhi T; Hindu K; Maheshvari Y; Khushnidha YG; Kumaravel M; Srinivas KS; Manickavasagam M; Mangathayaru K
    J Cancer Res Ther; 2021; 17(1):136-141. PubMed ID: 33723144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and characteristics of herbal supplement usage among community pharmacy customers in a Malaysian population.
    Yeong SW; Choong YC
    Complement Ther Med; 2017 Dec; 35():92-108. PubMed ID: 29154074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.
    Agbabiaka TB; Spencer NH; Khanom S; Goodman C
    Br J Gen Pract; 2018 Oct; 68(675):e711-e717. PubMed ID: 30249608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family medicine physicians' perception and attitudes of herbal substances use in greater Lisbon region.
    Pereira da Silva A; Geraldes M; Díaz-Lanza AM; Kovacs I; Costa MC
    Phytomedicine; 2018 Aug; 47():1-11. PubMed ID: 30166093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of usage of herbal medicines among cancer patients.
    Tuna S; Dizdar O; Calis M
    J BUON; 2013; 18(4):1048-51. PubMed ID: 24344037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of traditional herbal medicine use among hypertensives living in South African communities.
    Hughes GD; Aboyade OM; Clark BL; Puoane TR
    BMC Complement Altern Med; 2013 Feb; 13():38. PubMed ID: 23414344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.
    Lee RT; Kwon N; Wu J; To C; To S; Szmulewitz R; Tchekmedyian R; Holmes HM; Olopade OI; Stadler WM; Von Roenn J
    Cancer; 2021 Jun; 127(11):1827-1835. PubMed ID: 33524183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding herb and dietary supplement use in patients with epilepsy.
    Kaiboriboon K; Guevara M; Alldredge BK
    Epilepsia; 2009 Aug; 50(8):1927-32. PubMed ID: 19486356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.
    Lee RT; Barbo A; Lopez G; Melhem-Bertrandt A; Lin H; Olopade OI; Curlin FA
    J Clin Oncol; 2014 Dec; 32(36):4095-101. PubMed ID: 25403205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey.
    Tangkiatkumjai M; Boardman H; Praditpornsilpa K; Walker DM
    BMC Complement Altern Med; 2013 Jul; 13():153. PubMed ID: 23815983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the impact of herb-drug combinations used by cancer patients.
    Alsanad SM; Howard RL; Williamson EM
    BMC Complement Altern Med; 2016 Oct; 16(1):393. PubMed ID: 27756298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usage of complementary and alternative medicine in gastrointestinal patients visiting the outpatients' department of a large tertiary care centre-views from Pakistan.
    Lail G; Luck N; Tasneem AA; Rai A; Laeeq SM; Majid Z
    Pan Afr Med J; 2016; 24():247. PubMed ID: 27800102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of, and factors associated with health supplement use in Dubai, United Arab Emirates: a population-based cross-sectional study.
    Abdulla NM; Aziz F; Blair I; Grivna M; Adam B; Loney T
    BMC Complement Altern Med; 2019 Jul; 19(1):172. PubMed ID: 31299957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplement usage by patients with cancer undergoing chemotherapy: does prognosis or cancer symptoms predict usage?
    Bardia A; Greeno E; Bauer BA
    J Support Oncol; 2007 Apr; 5(4):195-8. PubMed ID: 17500507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicine from the perspective of type II diabetic patients and physicians: what is the relationship?
    Alqathama A; Alluhiabi G; Baghdadi H; Aljahani L; Khan O; Jabal S; Makkawi S; Alhomoud F
    BMC Complement Med Ther; 2020 Feb; 20(1):65. PubMed ID: 32111222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary and alternative medicines during the third trimester.
    Pallivalapila AR; Stewart D; Shetty A; Pande B; Singh R; McLay JS
    Obstet Gynecol; 2015 Jan; 125(1):204-211. PubMed ID: 25560126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of dietary supplements by patients in the pre-operative period in the Czech Republic.
    Zubrova J; Pokladnikova J; Draessler J
    Int J Clin Pharm; 2020 Oct; 42(5):1304-1310. PubMed ID: 32556896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumers' attitude towards the use and safety of herbal medicines and herbal dietary supplements in Serbia.
    Samojlik I; Mijatović V; Gavarić N; Krstin S; Božin B
    Int J Clin Pharm; 2013 Oct; 35(5):835-40. PubMed ID: 23820895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of herbal medicine home use and concomitant use with pharmaceutical medicines in Jamaica.
    Picking D; Younger N; Mitchell S; Delgoda R
    J Ethnopharmacol; 2011 Sep; 137(1):305-11. PubMed ID: 21645607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.